Abstract

Objective: To determine frequency of acceptance, follow up and outcome (safety and efficacy) of postpartum intrauterine contraceptive device in C section and vaginal delivery.

Study Design: Randomized clinical trial

Place and Duration of Study: Department of Gynecology & Obstetrics at CMH Peshawar from 1st June 2019 to 29th February 2020.

Methodology: One hundred fifty two women were included and were randomly divided into two groups; Group A underwent vaginal delivery while Group B underwent C-section. CuT-380A intrauterine contraceptive device was used in both groups. Patients were followed after 12 weeks.

Results: Mean age of women was 29.9±5.2 years. Acceptance of postpartum intrauterine contraceptive device was 13.8% in women underwent vaginal delivery and 11.2% in women underwent C-section delivery. There was no significant difference in follow up of both groups. Vaginal delivery group had more pregnancy and discontinuance after postpartum intrauterine contraceptive device insertion as compare to C-section (p=0.05 & p= 0.04 respectively). C-section group had more expulsions as compared to women undergone vaginal delivery (p=0.05). An insignificant difference in perforation, unusual vaginal discharge, infection and irregular bleeding was found in both group (p>0.005)

Conclusion: Postpartum intrauterine contraceptive devices are safe, effective and convenient contraceptive intervention in both vaginal and C-section deliveries. Postpartum intrauterine contraceptive device should be inserted by trained and skilled clinicians for reducing complications associated with insertion.

Key words C-section, Postpartum intrauterine contraceptive device (PPIUCD), Vaginal delivery